• About Us
    • Overview
    • Education
    • Mission & History
    • Board of Directors
    • The Campus
    • Careers
  • Our Achievements
    • Overview
    • Cancer
    • Technology
    • Education
    • Our Planet
    • Health & Medicine
    • Physical World
  • Get Involved
    • Overview
    • Partners in Science
    • Estate & Planned Giving
    • Attend an Event
    • Gift Opportunities
  • News & Media
    • Overview
    • News & Media Archive
    • Coronavirus
    • Feature Stories
    • News Releases
    • In The News
    • Video Gallery
    • Ad Campaigns
    • Celebrating Great Minds
  • Blog
  • Contact
  • Donate
Donate
Donate
About Us tri
About Us Overview
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements tri
Our Achievements Overview
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved tri
Get Involved Overview
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media tri
News & Media Overview
  • News & Media Archive
  • Coronavirus
  • Feature Stories
  • News Releases
  • In The News
  • Video Gallery
  • Ad Campaigns
  • Celebrating Great Minds
News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog tri
  • The Curiosity Review
Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Contact

Search Results

  • SEARCH BY KEYWORD
  • SEARCH BY TAG
View Articles by Tag:
  • View Articles by Tag
  • Algorithims (6)
  • Alternative energy (27)
  • Alzheimers (44)
  • Archaeology (37)
  • Artificial intelligence (20)
  • Astrophysics (108)
  • Autism (22)
  • Awards (119)
  • Bacteria (107)
  • Behavior (9)
  • Biochemistry (101)
  • Biofuel (7)
  • Biology (309)
  • Biomolecular sciences (7)
  • Blood (43)
  • Brain (175)
  • Cancer (163)
  • Cancer treatment (127)
  • Central nervous system (9)
  • Chemistry (78)
  • Children (7)
  • Circadian clock (1)
  • Climate change (73)
  • Clinical trials (40)
  • Collaborations (19)
  • Community (279)
  • Computers (73)
  • Copaxone (12)
  • Coronavirus (7)
  • Culture (359)
  • Diabetes (32)
  • Earth (74)
  • Education (157)
  • Environment (92)
  • Enzymes (29)
  • Evolution (89)
  • Fertility (20)
  • Fungus (4)
  • Genetics (109)
  • Genomics (3)
  • Heart (5)
  • Heart disease (3)
  • Humanity (83)
  • Immune system (149)
  • Immunology (10)
  • Immunotherapy (34)
  • Inflammation (19)
  • Leadership (114)
  • Leukemia (12)
  • Materials (44)
  • Mathematics (62)
  • Medicine (84)
  • Memory (39)
  • Mental health (58)
  • Metabolism (51)
  • Microbiology (2)
  • Microbiome (10)
  • Molecular cell biology (9)
  • Molecular genetics (61)
  • Multiple sclerosis (12)
  • Nanoscience (33)
  • Nature (4)
  • Neurobiology (2)
  • Neuroscience (207)
  • Nutrition (72)
  • Optics (34)
  • Organs (11)
  • Parkinsons (11)
  • Personalized medicine (5)
  • Philanthropy (148)
  • Physics (139)
  • Plants (56)
  • Proteins (96)
  • Quantum computer (3)
  • Quantum physics (2)
  • Quantum theory (34)
  • Robots (8)
  • Security (21)
  • Senses (115)
  • Sensors (8)
  • Smoking (1)
  • Solar power (19)
  • Space (110)
  • Stem cells (49)
  • Technology (206)
  • Vaccine (40)
  • Virus (135)
  • Water (40)
  • Weather (1)
  • Women (115)
  • World hunger (17)
Filter by Time:
  • All
  • Past Day
  • Past Week
  • Past Month
  • Past Year
  • Past Three Years
Clear Filters

127 results for Cancer treatment

Double Whammy for Triple-Negative Breast Cancer
Double Whammy for Triple-Negative Breast Cancer

https://www.weizmann-usa.org/news-media/news-releases/double-whammy-for-triple-negative-breast-cancer/

Nov 30, 2016... Combining two inhibitors (right) was much more effective than either alone in preventing cancer growth.
A promising new combination therapy for a particularly aggressive form of breast cancer has been identified by Weizmann Institute scientists, as was recently reported in the journal Cancer Research. The potential dual-acting therapeutic strategy not only inhibits tumor growth and survival but also circumvents the problem of drug-induced resistance.

TAGS: Women, Cancer, Cancer treatment

Triple Treatment Keeps Cancer from Coming Back
Triple Treatment Keeps Cancer from Coming Back

https://www.weizmann-usa.org/news-media/news-releases/triple-treatment-keeps-cancer-from-coming-back/

Jun 03, 2015... Lung cancer cells (green) cultured together with normal lung cells (red). The triple-antibody combination EGFR, HER2, and HER3 strongly impairs the survival of tumor cells while sparing normal cells. Modified confocal microscopy image: Maicol Mancini, lab of Prof. Yosef Yarden
Lung cancer is the leading cause of cancer death worldwide, responsible for some 1.59 million deaths a year. That figure is due, in part, to the fact that lung cancer often returns after what seems at first to be successful treatment. However, the recurring cancer is often resistant to the chemotherapy and other drugs that originally drove it into remission. But now, according to new research by the Weizmann Institute of Science’s Prof. Yosef Yarden, a new strategy involving a three-pronged approach might keep an aggressive form of lung cancer from returning.

TAGS: Cancer, Biology, Cancer treatment

To Stop Cancer, Block Its Messages
To Stop Cancer, Block Its Messages

https://www.weizmann-usa.org/news-media/news-releases/to-stop-cancer-block-its-messages/

Mar 30, 2015... REHOVOT, ISRAEL—March 30, 2015—The average living cell needs communication skills: It must transmit a constant stream of messages quickly and efficiently from its outer walls to the inner nucleus, where most of the day-to-day decisions are made. But this rapid, long-distance communication system leaves itself open to mutations that can give rise to a “spam attack” that promotes cancer. Prof. Rony Seger of the Department of Biological Regulation and his team have now proposed a method of shutting off the overflow of information before it can get to the nucleus. If the initial promising results hold up, the method could be used to treat a number of different cancers – especially several that develop resistance to current treatments – and might possibly induce fewer side effects than those treatments do. These findings appeared on March 30, 2015, in Nature Communications.

TAGS: Cancer, Biology, Cancer treatment

Time to Rethink Chemotherapy?
Time to Rethink Chemotherapy?

https://www.weizmann-usa.org/news-media/in-the-news/time-to-rethink-chemotherapy/

Jun 14, 2012... Leukemia cells dividing. Photo courtesy of Public Library of Science
For cancer patients undergoing treatment, the ups and downs can feel like living through one of those B-level movies where the zombies just never seem to die: Victories of remission can quickly end in disappointment as the cancer returns once more.
Why this happens has long puzzled scientists around the globe, but a new multi-center team in Israel whittles the problem down to the roots of where cancer begins.

TAGS: Cancer, Cancer treatment, Leukemia

Mother Nature to the Rescue
Mother Nature to the Rescue

https://www.weizmann-usa.org/news-media/feature-stories/mother-nature-to-the-rescue/

Apr 30, 2012... Natural molecules that protect the body against disease are finding their way into the treatment of advanced cancer. Prof. Michel Revel of the Department of Molecular Genetics has played a leading role in the discovery and study of two natural molecules now employed as drugs. In the late 1970s, Prof. Revel isolated the gene for interferon-beta, a human protein that fights viral infection in the body and is used as a drug against a variety of ills, including certain types of cancer—particularly glioma and non-small-cell lung carcinoma.

TAGS: Cancer, Cancer treatment, Proteins

Miracle Drug with Israeli Roots Saves Jewish Hockey Player Hit With Cancer
Miracle Drug with Israeli Roots Saves Jewish Hockey Player Hit With Cancer

https://www.weizmann-usa.org/news-media/in-the-news/miracle-drug-with-israeli-roots-saves-jewish-hockey-player-hit-with-cancer/

Mar 08, 2017... Hockey player Sam Fields was diagnosed with cancer at age 27, just weeks before he was scheduled to go to NHL training camp. (Courtesy ICRF)
This story is sponsored by the Israel Cancer Research Fund.
CHICAGO — Hockey had been the focal point of Sam Fields’ life for almost as long as he can remember.
A Chicago native who got into the sport at the age of eight, Fields had been playing professional hockey for about five years when he was tapped for a tryout with the National Hockey League. At the age of 27, he was on the cusp of becoming one of a handful of Jews in the NHL.

TAGS: Cancer, Cancer treatment

Repairing DNA, Fighting Cancer
Repairing DNA, Fighting Cancer

https://www.weizmann-usa.org/news-media/feature-stories/repairing-dna-fighting-cancer/

Sep 17, 2018... Prof. Zvi Livneh
Our genetic material – DNA – is under constant assault. It is damaged every day by external forces like sunlight, radiation, tobacco smoke, air pollution, and food additives, and internal ones like waste products left over from the body’s metabolic processes.
“The DNA of each cell in your body is damaged about 50,000 times each day,” says Prof. Zvi Livneh. “That’s a massive attack.”

TAGS: Genetics, Cancer, Biology, Cancer treatment, Enzymes

A Year of Achievements and Advances
A Year of Achievements and Advances

https://www.weizmann-usa.org/news-media/feature-stories/a-year-of-achievements-and-advances/

Jan 18, 2017... The prostate cancer therapy Tookad® is the product of a decades-long cross-disciplinary partnership between a plant scientist, Prof. Avigdor Scherz, and a biochemist, Prof. Yoram Salomon. The chlorophyll-based method destroys the tumor but not the healthy tissue nearby – and without the quality-of-life impacts of other prostate cancer treatments. This past year, Mexico approved Tookad® for treatment of early stage prostate cancer. Europe and Israel are nearing approval, and late-stage clinical trials are ongoing at New York’s Memorial Sloan Kettering Cancer Center.

TAGS: Culture, Community, Humanity, Cancer treatment

Targeting Tumors: A New Strategy for Prostate Cancer Treatment
Targeting Tumors: A New Strategy for Prostate Cancer Treatment

https://www.weizmann-usa.org/news-media/feature-stories/targeting-tumors-a-new-strategy-for-prostate-cancer-treatment/

Mar 02, 2010... Prof. Yoram Salomon (left) and Prof. Avigdor Scherz (right)
By combining three individually innocuous components, Weizmann Institute of Science researchers Prof. Yoram Salomon of the Department of Biological Regulation and Prof. Avigdor Scherz of the Department of Plant Sciences have created a toxic combination that destroys solid tumors. This cancer therapy, which is the result of nearly 20 years of collaboration between the two scientists, is being studied as a frontline treatment for prostate cancer. However, the strategy may work for other types of cancer as well. "In principle, right now, every solid tumor is potentially a target for this treatment," says Prof. Salomon.

TAGS: Technology, Chemistry, Cancer treatment, Clinical trials

Metastasis of Colon Cancer Cells Reversed In Vitro
Metastasis of Colon Cancer Cells Reversed In Vitro

https://www.weizmann-usa.org/news-media/news-releases/metastasis-of-colon-cancer-cells-reversed-in-vitro/

Jan 05, 2004... Weizmann Institute scientists have succeeded in reversing the metastatic properties of colon cancer cells, in vitro. The findings, published in The Journal of Cell Biology, uncover a key process involved in the metastasis of colon cancer cells and raise hopes that target-specific drugs might be devised to prevent, or reverse, the invasive behavior of metastatic colon cancer cells. Colon cancer is the second most-prevalent type of cancer in men and third in women in the Western world.

TAGS: Cancer, Cancer treatment

First 1 2 3 4 5 6 7 8 9 10 ... Last
Back Next
SHARE

Our Achievements

Learn more about remarkable Weizmann Institute achievements that are enhancing and transforming our lives.

Learn More

Support Our Flagship Projects

Help us accelerate exciting initiatives in three forward-looking fields: neuroscience, physics, and artificial intelligence.

Learn More

Newsletter

Get the latest news and breakthroughs from the Weizmann Institute of Science.

About Us
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
Our Achievements
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Get Involved
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
News & Media Blog: Curiosity Review Donate Now Contact Us
Privacy Policy Gift Acceptance Policy Financial Information

©2023 American Committee for the Weizmann Institute of Science

Charity Navigator

FOR THE FOURTH CONSECUTIVE YEAR

Platinum Transparency 2023